Director

In addition to his role as Director of the Colton Center for Autoimmunity at NYU Langone, Dr. Scher is the Steve Abramson Associate Professor of Medicine, Associate Director of Research and Translational Medicine for the Division of Rheumatology, and the Director of the Psoriatic Arthritis Center (PAC).

Through the work at the PAC, a clinical and translational hub for the study of psoriatic disease, a team of rheumatologists, dermatologists, immunologists, and computational scientists work together to address the many unmet needs in the field. Dr. Scher’s research interests include the immune and environmental features that enhance risk for transition from psoriasis to psoriatic arthritis (PsA), the mechanisms behind inflammation in psoriatic and rheumatoid disease, and the pharmacomicrobiomics of DMARDs and immunotherapies in human RA and PsA. His work is supported by grants from the NIH/NIAMS, the Rheumatology Research Foundation, National Psoriasis Foundation, and Bloomberg Philanthropies, among others.

Dr. Scher directs the NYU Langone Advanced Course in Psoriasis and Psoriatic Arthritis. He is past member of the FDAs Arthritis Advisory Committee (2016–2020), and currently serves as chair of the NPF Scientific Advisory Committee (2021) and as standing member of the NIH-ACTS study section (2021). He received his MD in Buenos Aires, Argentina, where he completed training in human genetics and clinical immunology. He went on to complete his internal medicine residency and rheumatology fellowship at NYU.

Co-Director

Dr. Buyon, MD, Co-Director of the Colton Center for Autoimmunity at NYU Langone, is also the Sir Deryck and Lady Va Maughan Professor of Rheumatology and the Director of the Division of Rheumatology at NYU Grossman School of Medicine.

Dr. Buyon is a physician–scientist specializing in translational research and management of systemic lupus erythematosus, lupus nephritis, neonatal lupus, and rheumatic diseases in pregnancy. In 1994, Dr. Buyon founded the Research Registry for Neonatal Lupus, the largest extant registry of its kind and a major font of information on this disease. She established the division-wide SAMPLE biorepository (Specimen and Matched Phenotype Linked Evaluation) to facilitate seamless integration of phenotype and sample storage with one protocol and consent. This resource has been used for dozens of multidisciplinary collaborations across a broad variety of disease areas. Her research has been supported by NIH funding through the Accelerating Medicines Partnership, a MERIT Award, a P50 Center, and several R01s, and other mechanisms. Along with Dr. Scher, she is mPI on the Division of Rheumatology’s T32 Training Grant.

Dr. Buyon has received the Distinguished Clinical Investigator Award, the Evelyn V. Hess Lifetime Achievement Award for Research in Lupus, and the Halsted R. Holman Award for Excellence in Clinical Research and was elected to the Association of American of Physicians. She has served on numerous NIH committees, including six years on the Arthritis and Musculoskeletal Diseases K and T32 Award grant peer review committee, four years on the NIH Peer Review Advisory Committee (PRAC), and four years on the NIAMS Advisory Council.

Administrative Manager